Dr. Harold R. Collard is an assistant professor of medicine in UCSF's Division of Pulmonary and Critical Care Medicine and the Director of the Interstitial Lung Disease Program at UCSF. His primary interest is in the management of patients with interstitial lung disease, including how best to diagnose and treat interstitial lung disease and how the condition impacts a patient's quality of life and survival.
Dr. Collard earned a medical degree at Duke University. He completed an internship, residency and chief residency in internal medicine at UCSF as well as a fellowship in pulmonary and critical care medicine at the University of Colorado. Prior to joining UCSF, Dr. Collard was a member of the Interstitial Lung Disease Program at the National Jewish Medical and Research Center in Denver. Dr. Collard regularly sees patients with interstitial lung disease as part of the UCSF Interstitial Lung Disease Clinic (415-353-8764 (phone), http://www.ucsfhealth.org/ild).
Dr. Collard is a clinical and translational researcher focused on patients and populations of patients with interstitial lung disease. Dr. Collard is currently conducting projects investigating: (1) the biology of acute exacerbations of idiopathic pulmonary fibrosis (acute events that cause significant worsening of disease for many patients); (2) factors contributing to patients’ symptoms of shortness of breath and ways to improve patients’ quality of life; (3) clinical trials of promising but unproven therapies for patients with interstitial lung disease. Dr. Collard also supervises the UCSF ILD Program clinical database which contains data from over 1000 patients with various forms of interstitial ling disease.
Collard Harold R., Talmadge E. King Jr, Becki Bucher-Bartelson, Jason V. Vourlekis, Marvin I. Schwarz, and Kevin K. Brown. Changes in clinical and physiologic variables predict survival in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 2003;168:538-542.
Collard Harold R., Jay H. Ryu, William W. Douglas, Marvin I. Schwarz, Douglas Curran-Everett, Talmadge E. King, Jr., and Kevin K. Brown. Combined corticosteroid and cyclophosphamide therapy does not alter survival in Idiopathic Pulmonary Fibrosis. Chest 2004;125:2169-2174.
Janssen, William J., Harold R. Collard, Sanjay Saint, and Steven E. Weinberger. A Perfect Storm. New England Journal of Medicine 2005;353:1956-1961.
Wolter, Nicholas, Harold R. Collard, and Talmadge E. King, Jr. Current Perspectives on the Treatment of Idiopathic Pulmonary Fibrosis. Proceedings of the American Thoracic Society 2006;3:330-338.
Kim, Dong Soon, Harold R. Collard, and Talmadge E. King Jr. Classification and Natural History of the Idiopathic Interstitial Pneumonias. Proceedings of the American Thoracic Society 2006;3:285-292.
Collard, Harold R., Carlyne D. Cool, Kevin O. Leslie, Douglas Curran-Everett, Steve Groshong, and Kevin K. Brown. Organizing Pneumonia and Lymphoplasmacytic Inflammation Predict Treatment Response in Idiopathic Pulmonary Fibrosis. Histopathology 2007;50:258-265.
Collard, Harold R., Gregory Tino, Paul W. Noble, Mark A. Shreve, Maureen Michaels, Bruce Carlson, and Marvin I. Schwarz. Patient perceptions of Idiopathic Pulmonary Fibrosis: A Survey. Respiratory Medicine 2007;101:1350-4.
Zamora, Ana C., Harold R. Collard, Paul J. Wolters, W. Richard Webb, and Talmadge E. King, Jr. Neurofibromatosis-Associated Lung Disease: A Case Series and Literature Review. European Respiratory Journal 2007;29:210-214.
Collard, Harold R., Kevin J. Anstrom, Marvin I. Schwarz, and David A. Zisman. Sildenafil Improves Walk Distance in Idiopathic Pulmonary Fibrosis. Chest 2007;131:897-899.
Collard, Harold R., James E. Loyd, Talmadge E. King Jr., Lisa H. Lancaster. Current Diagnosis and Management of Idiopathic Pulmonary Fibrosis: A Survey of Academic Physicians. Respiratory Medicine 2007;101;2011-6.
Collard, Harold R., Bethany B. Moore, Kevin R. Flaherty, Kevin K. Brown, Robert J. Kaner, Talmadge E. King, Jr., Joseph A Lasky, James E. Loyd, Imre Noth, Mitchell A. Olman, Ganesh Raghu, Jesse Roman, Jay H. Ryu, David A Zisman, Gary W. Hunninghake, Thomas V Colby, Jim J. Egan, David M. Hansell, Takeshi Johkoh, Naftali Kaminski, Dong Soon Kim, Yasuhiro Kondoh, David A Lynch, Joachim Müller-Quernheim, Jeffrey L. Myers, Andrew G Nicholson, Moises Selman, Galen B. Toews, Athol U. Wells, and Fernando J. Martinez. Pulmonary Perspective: Acute Exacerbation of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 2007;176:636-643.
Kinder, Brent W., Harold R. Collard, Laura Koth, David I. Daikh, Paul J. Wolters, Brett Elicker, Kirk Jones, Talmadge E. King, Jr. The clinical entity “idiopathic Nonspecific Interstitial Pneumonia”: an autoimmune disease and the lung manifestation of Undifferentiated Connective Tissue Disease. American Journal of Respiratory and Critical Care Medicine 2007;176:691-7.
Zamora, Ana C., Paul J. Wolters, Harold R. Collard, M. Kari Connolly, Brett M. Elicker, W. Richard Webb, Talmadge E. King Jr., Jeffrey A. Golden. Use of mycophenolate mofetil to treat scleroderma associated interstitial lung disease. Respiratory Medicine 2008;102:150-5.
Ferreira, Alicia, Chris Garvey, Gerilynn Conners, Lana Hilling, Julia Rigler, Susan Farrell, Cindy Cayou, Cyrus Shariat, and Harold R Collard. Pulmonary rehabilitation in Interstitial Lung Disease: Benefits and predictors of response. Chest 2009;135:442.
|
